Valley Biosciences

Valley Biosciences is rewriting the story of aging by tackling its root cause: the DNA damage and cellular senescence that accumulate over time and spark inflammation, tissue dysfunction, and disease. Our mission is to pioneer treatments that repair genomic integrity, clear harmful senescent cells, and quiet age‑associated inflammation—ultimately extending healthy human lifespan for generations to come. Drawing on deep expertise in molecular biology and immunology, we have built a multi‑platform pipeline that addresses every step of the cellular‑aging continuum. Restoring DNA‑repair signaling, recruiting the immune system to eliminate pathogenic senescent cells, and inhibiting DNA‑damage‑driven inflammation; together our drug candidates represent a coordinated strategy to slow, halt, or even reverse age‑related decline. All three programs are advancing through pre‑clinical development with rigorous mechanistic validation. Our goal is nothing short of redefining preventive care: transforming today’s breakthroughs into tomorrow’s standard therapies so that chronic, age‑linked illnesses are delayed, diminished, or avoided altogether. By turning foundational science into practical interventions, Valley Biosciences aims to add not just years to life but vitality to those years. We are actively partnering with academics, biopharma innovators, and impact‑minded investors who share our conviction that aging itself can be treated. If you’re ready to help shape a future in which longer, healthier lives are the norm, we’d love to connect.